Skip to content
AlternativeMed

"Natural Is Safer" and Other Natural vs Synthetic Safety Claims

A claim check on "natural is safer" for psychoactive plants and fungi versus lab-made or clinical products, covering variability, contamination, toxic look-alikes and what trials used.

Content last updated . This page has not been medically reviewed.

The claim

"It is natural, so it is safer than a synthetic drug" is one of the most common safety claims about psychedelics and related substances. This page checks it. The short version: where a substance comes from does not by itself tell you how safe it is. The questions that matter are what exactly is in the product, how much, who is taking it, and under what conditions. Evidence labels: marketing claim, evidence of harm, insufficient evidence and Proper evidence not found.

Three things that get mixed up

  1. The compound. Psilocybin is a chemical. It can occur in certain mushrooms and can also be made in a laboratory.
  2. The source organism or preparation. A mushroom contains many substances, and amounts can differ from one specimen or batch to the next.
  3. A clinical product. A standardized, tested formulation given in a research setting with screening and support.

"Natural" describes where something came from. "Synthetic" describes how it was made. Neither word describes risk. For the broader principle, see Natural Does Not Mean Safe and Natural vs Synthetic Psychoactive Substances.

What the clinical trials used

The psilocybin trials in depression used synthetic psilocybin or a proprietary synthetic formulation, given with psychological support. [1][2] Their results are about those products in those settings. They do not show that mushrooms, truffles or edibles are safe or effective. See Clinical Formulations vs Nonmedical Products.

Natural does not mean consistent

In a laboratory analysis of dried Psilocybe cubensis mushroom material grown under uniform controlled conditions, the researchers still found batch variability, with significant differences in projected dosage, and recommended that each batch be tested. [3] If variability appears even under controlled conditions, material grown or sold elsewhere cannot be assumed to be more consistent. Do not extrapolate from one sample to any species or product. See Commercial Mushroom Names.

Unregulated products

Poison center data reviewed for 2023 and 2024 (362 psychoactive mushroom edible exposures) describe these unregulated products as widely available, often with unlisted ingredients and inconsistent formulations. [4] The effects of mushroom edible ingestion were described as unpredictable, with clinical presentations varying widely, and no deaths were reported in that dataset. [4] In a case series from three poison centers, the median age of patients was 17. [5] Several cases of serious clinical effects related to mushroom-containing products had been reported to the FDA. [5] Label: evidence of harm for some unregulated products, and no claim that all such products are harmful. See Unverified Mushroom Gummies and Similar Products.

Natural toxins are still toxins

Amanita muscaria (fly agaric) is a natural mushroom. A 2025 review called it a clinically important cause of acute mushroom intoxication and noted that its toxic profile is highly variable. [6] It is a separate organism from psilocybin-containing mushrooms; do not confuse them. See Amanita muscaria, Muscimol and Ibotenic Acid and Poisoning and Misidentification.

What about psilocybin itself?

NIDA says psilocybin has a low level of toxicity, meaning a low potential of causing potentially fatal events like breathing problems or a heart attack, but that there are health risks, particularly when unsupervised and outside a research study and clinical supervision. [7] It also says psilocybin typically raises blood pressure and heart rate. [7] These are statements about the compound. They do not turn a mushroom product with unknown contents into a safe one.

Is natural safer than synthetic?

Proper evidence not found. We searched PubMed on October 22, 2026 for studies directly comparing the safety of natural mushroom material with synthetic psilocybin and found none. So the claim "natural is safer" is a marketing claim unsupported by comparison studies, and the opposite claim, "synthetic is safer", is also unsupported. What can be said is that standardized, tested products used under supervision are easier to evaluate than products with unknown contents.

How to evaluate a safety claim

  • Ask what the claim is about: the compound, the plant or fungus, or a specific product.
  • Ask who tested it and what was measured.
  • Be cautious when a claim relies on tradition, testimonials or the word "natural".
  • Check for a safety page on Evaluating Safety Claims.

If someone has swallowed an unknown mushroom or product and seems ill, call 911 or US Poison Help at 1-800-222-1222. For a mental health crisis in the US, call or text 988.

Frequently asked questions

Are natural psychedelics safer than synthetic ones?

No study we read shows that. Source does not determine safety; content, amount, setting and the person all matter. [4]

Are psilocybin mushrooms the same as the psilocybin used in trials?

No. The trials used synthetic psilocybin or a synthetic formulation. [1][2] Mushroom material can vary from batch to batch. [3]

Are mushroom gummies and chocolates regulated?

The poison center analysis described these products as unregulated. [4]

Is Amanita muscaria a milder alternative to psilocybin mushrooms?

No. It is a different organism with its own toxicology, and poisoning cases occur. [6]

If psilocybin has low toxicity, is it safe?

Low toxicity is not the same as safe. NIDA lists dangerous behavior, raised blood pressure and heart rate, and other risks. [7]

References

  1. Raison CL, et al. JAMA 2023. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial Read 2026-10-22.
  2. Goodwin GM, et al. New England Journal of Medicine 2022. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression Read 2026-10-22.
  3. Foster K, et al. Journal of AOAC International 2026. Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi Read 2026-10-22.
  4. Jorgenson DM, et al. Clinical Toxicology 2026. Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System, 2023-2024 Read 2026-10-22.
  5. Gartner HT, et al. American Journal of Emergency Medicine 2024. Psychedelic mushroom-containing chocolate exposures: Case series Read 2026-10-22.
  6. Stoeva-Grigorova S, et al. Toxins 2025. Acute Amanita muscaria Toxicity: A Literature Review and Two Case Reports in Elderly Spouses Following Home Preparation Read 2026-10-22.
  7. National Institute on Drug Abuse (NIDA). Psilocybin (Magic Mushrooms). Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.